Neurocritical Care

, 10:166 | Cite as

Vasopressors and Propofol Infusion Syndrome in Severe Head Trauma

Original Article
First Online:
Received:
Accepted:

Abstract

Introduction

Propofol infusion syndrome (PRIS) is a rare, but lethal complication of high-dose propofol infusions. We undertook this study to evaluate the incidence of PRIS in a cohort of patients with severe head trauma and its relation to the use of vasopressors.

Methods

We reviewed all patients with severe head trauma admitted to our Neuro-Intensive Care Unit over a 4-year period for use of propofol and vasopressors. Those patients who developed unexplained acidosis, creatine kinase elevation unrelated to trauma, and electrocardiographic changes were considered having PRIS. We investigated the concomitant use of vasopressors while propofol was used and calculated odds ratios for developing PRIS.

Results

We report three adult patients who developed PRIS out of 50 (6%) admitted patients with severe head trauma on propofol infusions. Two of these patients survived and one expired after withdrawal of life support. Concomitant use of vasopressors was associated with development of PRIS in this cohort (odds ratio 29, 95% CI 1.5–581, P < 0.05).

Conclusions

Awareness and early recognition of PRIS in critically ill neurosurgical patients on vasopressors and daily screening for creatine kinase elevation, unexplained acidosis, or electrocardiographic changes may reduce the incidence and case-fatality.

Keywords

Propofol infusion syndrome Vasopressors Catecholamines Rhabdomyolysis Traumatic head injury 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ. 1992;305:613–6.PubMedGoogle Scholar
  2. 2.
    Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth. 1998;8:491–9. doi: 10.1046/j.1460-9592.1998.00282.x.PubMedCrossRefGoogle Scholar
  3. 3.
    Marinella MA. Lactic acidosis associated with propofol. Chest. 1996;109:292. doi: 10.1378/chest.109.1.292.PubMedCrossRefGoogle Scholar
  4. 4.
    Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology. 1998;50:301–3.PubMedGoogle Scholar
  5. 5.
    Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Crit Care Med. 2000;28:3071–4. doi: 10.1097/00003246-200008000-00066.PubMedCrossRefGoogle Scholar
  6. 6.
    Hutchens MP, Memtsoudis S, Sadovnikoff N. Propofol for sedation in neuro-intensive care. Neurocrit Care. 2006;4:54–62. doi: 10.1385/NCC:4:1:054.PubMedCrossRefGoogle Scholar
  7. 7.
    Varelas PN, Eastwood D, Yun HJ, et al. Impact of a neurointensivist on outcomes in patients with head trauma treated in a neurosciences intensive care unit. J Neurosurg. 2006;104:713–9. doi: 10.3171/jns.2006.104.5.713.PubMedCrossRefGoogle Scholar
  8. 8.
    Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117–8. doi: 10.1016/S0140-6736(00)03547-9.PubMedCrossRefGoogle Scholar
  9. 9.
    Wysowski DK, Pollock ML. Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review. Anesthesiology. 2006;105:1047–51. doi: 10.1097/00000542-200611000-00027.PubMedCrossRefGoogle Scholar
  10. 10.
    Fong JJ, Sylvia L, Ruthazer R, Schumaker G, Kcomt M, Devlin JW. Predictors of mortality in patients with suspected propofol infusion syndrome. Crit Care Med. 2008;36:2281–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119–41. doi: 10.1097/00003246-200201000-00020.PubMedCrossRefGoogle Scholar
  12. 12.
    Barr J, Egan TD, Sandoval NF, et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic–pharmacodynamic model. Anesthesiology. 2001;95:324–33. doi: 10.1097/00000542-200108000-00011.PubMedCrossRefGoogle Scholar
  13. 13.
    Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62:690–701. doi: 10.1111/j.1365-2044.2007.05055.x.PubMedCrossRefGoogle Scholar
  14. 14.
    Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29:1417–25. doi: 10.1007/s00134-003-1905-x.PubMedCrossRefGoogle Scholar
  15. 15.
    Karakitsos D, Poularas J, Kalogeromitros A, Karabinis A. The propofol infusion syndrome treated with haemofiltration. Is there a time for genetic screening? Acta Anaesthesiol Scand. 2007;51:644–5. doi: 10.1111/j.1399-6576.2007.01266.x.PubMedCrossRefGoogle Scholar
  16. 16.
    Kumar MA, Urrutia VC, Thomas CE, Abou-Khaled KJ, Schwartzman RJ. The syndrome of irreversible acidosis after prolonged propofol infusion. Neurocrit Care. 2005;3:257–9. doi: 10.1385/NCC:3:3:257.PubMedCrossRefGoogle Scholar
  17. 17.
    Wolf A, Weir P, Segar P, Stone J, Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001;357:606–7. doi: 10.1016/S0140-6736(00)04064-2.PubMedCrossRefGoogle Scholar
  18. 18.
    Uezono S, Hotta Y, Takakuwa Y, Ozaki M. Acquired carnitine deficiency: a clinical model for propofol infusion syndrome? Anesthesiology. 2005;103:909. doi: 10.1097/00000542-200510000-00046.PubMedCrossRefGoogle Scholar
  19. 19.
    Mehta N, DeMunter C, Habibi P, Nadel S, Britto J. Short-term propofol infusions in children. Lancet. 1999;354:866–7. doi: 10.1016/S0140-6736(05)75936-5.PubMedCrossRefGoogle Scholar
  20. 20.
    Rosen DJ, Nicoara A, Koshy N, Wedderburn RV. Too much of a good thing? Tracing the history of the propofol infusion syndrome. J Trauma. 2007;63:443–7. doi: 10.1097/TA.0b013e31809fe910.PubMedCrossRefGoogle Scholar
  21. 21.
    Casserly B, O’Mahony E, Timm EG, Haqqie S, Eisele G, Urizar R. Propofol infusion syndrome: an unusual cause of renal failure. Am J Kidney Dis. 2004;44:e98–101. doi: 10.1053/j.ajkd.2004.08.036.PubMedCrossRefGoogle Scholar
  22. 22.
    Sabsovich I, Rehman Z, Yunen J, Coritsidis G. Propofol infusion syndrome: a case of increasing morbidity with traumatic brain injury. Am J Crit Care. 2007;16:82–5.PubMedGoogle Scholar
  23. 23.
    Myburgh JA, Upton RN. Propofol use in head-injury patients. Lancet. 2001;357:1709–10. doi: 10.1016/S0140-6736(00)04842-X.PubMedCrossRefGoogle Scholar
  24. 24.
    Cremer OL, Moons KG, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head injured patients. (Authors reply). Lancet. 2001;357:(authors reply) 1709–10. doi: 10.1016/S0140-6736(00)04843-1.Google Scholar
  25. 25.
    FDA issues warning on propofol (Diprivan). Can Med Assoc J 2001;164:1608.Google Scholar
  26. 26.
    Anonymous. Propofol: danger of prolonged and high infusion rates in ICU. Aust Adv Drug React Bull. 2004;23:23–4.Google Scholar
  27. 27.
    Felmet K, Nguyen T, Clark RS, Orr D, Carcillo J. The FDA warning against prolonged sedation with propofol in children remains warranted. Pediatrics. 2003;112:1002–3. doi: 10.1542/peds.112.4.1002. (author reply) 1002–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Diprivan for I.V. Administration. U.S. Food and Drug Administration. Diprivan (NDA) 019627 Supplement number, 045:11.Google Scholar
  29. 29.
    Abrahams JM, Reiter GT, Acker MA, Sinson GP. Propofol. J Neurosurg. 2002;96:1160–1. (author reply) 1161.PubMedGoogle Scholar
  30. 30.
    Coetzee JF, Coetzer M. Propofol in paediatric anaesthesia. Curr Opin Anaesthesiol. 2003;16:285–90. doi: 10.1097/00001503-200306000-00008.PubMedCrossRefGoogle Scholar
  31. 31.
    Otterspoor LC, Kalkman CJ, Cremer OL. Update on the propofol infusion syndrome in ICU management of patients with head injury. Curr Opin Anaesthesiol. 2008;21:544–51. doi: 10.1097/ACO.0b013e32830f44fb.PubMedCrossRefGoogle Scholar
  32. 32.
    Ernest D, French C. Propofol infusion syndrome—report of an adult fatality. Anaesth Intens Care. 2003;31:316–9.Google Scholar
  33. 33.
    Corbett SM, Moore J, Rebuck JA, Rogers FB, Greene CM. Survival of propofol infusion syndrome in a head-injured patient. Crit Care Med. 2006;34:2479–83.PubMedCrossRefGoogle Scholar
  34. 34.
    Eriksen J, Povey HM. A case of suspected non-neurosurgical adult fatal propofol infusion syndrome. Acta Anaesthesiol Scand. 2006;50:117–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Zaccheo MM, Bucher DH. Propofol infusion syndrome: a rare complication with potentially fatal results. Crit Care Nurse. 2008;28:18–26; quiz 27.Google Scholar
  36. 36.
    Friedman JA, Manno E, Fulgham JR. Propofol. J Neurosurg. 2002;96:1161–2; (author reply) 1162.Google Scholar
  37. 37.
    Badr AE, Mychaskiw G, II, Eichhorn JH. Metabolic acidosis associated with a new formulation of propofol. Anesthesiology. 2001;94:536–8.Google Scholar
  38. 38.
    Fudickar A, Tonner PH, Mihaljovic Z, et al. Suggested beginning of propofol infusion syndrome in an adult patient without lactacidosis: a case report. Eur J Anaesthesiol. 2008;25:777–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Merz TM, Regli B, Rothen HU, Felleiter P. Propofol infusion syndrome—a fatal case at a low infusion rate. Anesth Analg. 2006;103:1050.PubMedCrossRefGoogle Scholar
  40. 40.
    Machata AM, Gonano C, Birsan T, Zimpfer M, Spiss CK. Rare but dangerous adverse effects of propofol and thiopental in intensive care. J Trauma. 2005;58:643–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem. 2000;46:577–81.PubMedGoogle Scholar
  42. 42.
    Salengros JC, Velghe-Lenelle CE, Bollens R, Engelman E, Barvais L. Lactic acidosis during propofol-remifentanil anesthesia in an adult. Anesthesiology. 2004;101:241–3.PubMedCrossRefGoogle Scholar
  43. 43.
    Chukwuemeka A, Ko R, Ralph-Edwards A. Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anaesth Intens Care. 2006;34:651–5.Google Scholar
  44. 44.
    Burow BK, Johnson ME, Packer DL. Metabolic acidosis associated with propofol in the absence of other causative factors. Anesthesiology. 2004;101:239–41.PubMedCrossRefGoogle Scholar
  45. 45.
    Liolios A, Guerit JM, Scholtes JL, Raftopoulos C, Hantson P. Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult. Anesth Analg. 2005;100:1804–6.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2008

Authors and Affiliations

  1. 1.Department of NeurosurgeryMedical College of WisconsinMilwaukeeUSA
  2. 2.Departments of Neurology and NeurosurgeryHenry Ford HospitalDetroitUSA

Personalised recommendations